Compound ID | 7

Update compound information

MEDI3902

Synonym(s): Gremubamab

Class: Antibody

Spectrum of activity: Gram-negative
Details of activity: Nosocomial pneumonia caused by Pseudomonas aeruginosa (P. aeruginosa)
Institute where first reported: Medimmune, USA
Year first mentioned: 2014
Highest developmental phase: Phase 2 (NCT04631016)
Development status: Active
External links:
Guide to Pharmacology: gremubamab
Main Source: https://www.medimmune.com/research/pipeline
Citations:
  • https://aac.asm.org/content/63/8/e00710-19
  • https://clinicaltrials.gov/ct2/show/NCT02255760?term=medi3902&rank=1
  • https://www.astrazeneca.com/media-centre/press-releases/2014/medimmune-fda-medi3902-nosocomial-pneumonia-prevention-23092014.html#

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us.

    Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.